Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine local injection for postoperative pain after tonsillectomy
IRCT20190511043550N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ropivacaine in postoperative pain and chronic tonsillitis (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Post-tonsillectomy pain. Started Dec 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative painchronic tonsillitis
Beyond the preview
Go deeper on IRCT20190511043550N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190511043550N3.